University Hospital, Brest: Lung Neoplasms trials

The registry lists 11 Lung Neoplasms studies with University Hospital, Brest as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 2 3Phase 3 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Functional Lung Avoidance Planning Guided by Lung Perfusion PET/CT Versus Anatomical Planning for Lung Stereotactic Body RadiotherapyRecruitingNCT07289646Phase 3
• PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1Not yet recruitingNCT06738680
• Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC)RecruitingNCT05996263
• Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients with NSCLCRecruitingNCT04886401
• Real-life Second-line Epirubicin-Paclitaxel Regimen as Treatment of Relapsed Small-Cell Lung Cancer : EpiTax Study.CompletedNCT06550518
• Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation TherapyStatus unknownNCT04942275Phase 2/3
• Immunological Markers Predictive of Response and Toxicity to Checkpoint Inhibitors in Non-small Cell Lung CancerStatus unknownNCT04918836
• Prediction of Esophageal and Lung Toxicities After Radiation (Chemo) TherapyCompletedNCT04545658
• Follow-up of Pulmonary Radiotoxicity for Bronchopulmonary Cancer.CompletedNCT03931356
• Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC)CompletedNCT00744900Phase 2
• Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC.CompletedNCT00295672Phase 2